WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007017514) MICROPARTICLE COMPOSITIONS OF THE TOPOISOMERASE I INHIBITOR 7-TERT-BUTOXYIMINOMETHYLCAMPTOTHECIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/017514    International Application No.:    PCT/EP2006/065160
Publication Date: 15.02.2007 International Filing Date: 08.08.2006
Chapter 2 Demand Filed:    02.05.2007    
IPC:
A61K 9/107 (2006.01), A61K 31/4745 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (For All Designated States Except US).
OTTINGER, Isabel [DE/DE]; (DE) (For US Only).
KALB, Oskar [DE/DE]; (DE) (For US Only).
STEBLER, Walter [CH/CH]; (CH) (For US Only).
TAILLARDAT, Agnes [CH/CH]; (CH) (For US Only).
WIRTH, Wolfgang [DE/CH]; (CH) (For US Only)
Inventors: OTTINGER, Isabel; (DE).
KALB, Oskar; (DE).
STEBLER, Walter; (CH).
TAILLARDAT, Agnes; (CH).
WIRTH, Wolfgang; (CH)
Agent: GRAFF, Alan; NOVARTIS, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
60/707,139 10.08.2005 US
Title (EN) MICROPARTICLE COMPOSITIONS OF THE TOPOISOMERASE I INHIBITOR 7-TERT-BUTOXYIMINOMETHYLCAMPTOTHECIN
(FR) COMPOSITIONS DE MICROPARTICULES CONTENANT UN INHIBITEUR DE LA TOPOISOMERASE 1, LA 7-TERT-BUTOXYIMINOMETHYLCAMPTOTHECINE
Abstract: front page image
(EN)The present invention relates to microparticle pharmaceutical compositions in which the active agent is a topoisomerase I inhibitor, in particular, 7-f-butoxyiminomethylcamptothecin, that is useful for the treatment and prevention of proliferative diseases including cancer.
(FR)Cette invention concerne des compositions pharmaceutiques de microparticules dans lesquelles le principe actif est un inhibiteur de la topoisomérase 1, plus particulièrement, la 7-tert-butoxyiminomethylcamptothécine, permettant de traiter et de prévenir des maladies proliférantes parmi lesquelles le cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)